#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leukoencephalopathy Necrotising enterocolitis neonatal Gaucher's disease type I Extraskeletal ossification Red blood cell abnormality Neurofibroma Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Cystic fibrosis respiratory infection suppression Friedreich's ataxia Neoplasm Brain injury Rheumatoid arthritis Oesophageal adenocarcinoma stage III Infective uveitis Gastroenteropancreatic neuroendocrine tumour disease More trials…

    Learn about Rare Diseases

    Mast cell activation syndrome – Basic Information Hypereosinophilic syndrome – Basic Information Rosai-Dorfman syndrome Hereditary motor and sensory neuropathy Ewing’s sarcoma recurrent – Diagnostics Hereditary optic atrophy Mantle cell lymphoma stage III – Trials in Disease Erdheim-Chester disease – Treatment Alport’s syndrome – Diagnostics Hyperoxaluria – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nitrous Oxide Octreotide Hydrochloride Dexrazoxane Hydrochloride Ziltivekimab Cart45Ra-Nkg2D Cells HUMAN COAGULATION FACTOR XIII AVTX-009 Clazakizumab COBALAMIN Aspergillus Fumigatus Cholesterol Rbl016.2 Basiliximab Icatibant Ibrexafungerp Mebendazole Vo659 Collagenase Mirodenafil Dihydrochloride Deucravacitinib More therapies…

    Learn about Your Condition

    Exfoliation glaucoma Carcinoid syndrome Endocrine disorder Hypoglycaemia Melanoma recurrent Lung disorder Cytokine release syndrome Autism spectrum disorder Acute leukaemia Myxofibrosarcoma Metabolic disorder Left ventricular dysfunction Suicidal ideation Bone hypertrophy Oedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Pozelimab and Cemdisiran for Adults with Geographic Atrophy from Age-Related Macular Degeneration

    Recruiting

    3 1
    Investigated Diseases:
    • Age-related macular degeneration
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Cemdisiran
    • Pozelimab
    Austria France Germany Hungary Italy Poland +1

  • Study on Triamcinolone Acetonide and Pulsed Radiofrequency for Chronic Shoulder Pain in Adults

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Arthralgia
    Investigated Drugs:
    • Triamcinolone Acetonide
    Spain

  • Study on How Nusinersen is Processed in Adults and Children with Spinal Muscular Atrophy Using the ThecaFlex DRx System

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Nusinersen
    France Germany Italy Poland Spain

  • Study of EG-70 for Patients with Non-Muscle Invasive Bladder Cancer Unresponsive to BCG or High-Risk Patients New to BCG or with Incomplete BCG Treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bladder cancer
    France Germany Italy Spain

  • Study on Stem Cell Transplantation and Immunotherapy with Rituximab, Dinutuximab Beta, and Drug Combination for Patients with High-Risk Relapsed Neuroblastoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • ALLOGENEIC PERIPHERAL BLOOD-DERIVED HAEMATOPOIETIC STEM CELLS, TCR ALPHA/BETA+ CD19+ DEPLETED
    • ALLOGENEIC PERIPHERAL BLOOD-DERIVED NK CELLS CD3- CD56+
    • Dinutuximab Beta
    Italy

  • Study on the Impact of Cefepime, Piperacillin-Tazobactam, and Ceftobiprole on Gut Health in Patients with Bone and Joint Infections on Implants

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Cefepime
    • Piperacillin
    • Daptomycin
    France
Previous Page
1 … 256 257 258 259 260 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!